Article Details

Coherus Biosciences (CHRS) Holder Carlson Capital LP Has Decreased Stake as Stock Price ...

Retrieved on: 2018-02-24 01:26:15

Tags for this article:

Click the tags to see associated articles and topics

Coherus Biosciences (CHRS) Holder Carlson Capital LP Has Decreased Stake as Stock Price .... View article details on hiswai:

Excerpt

<div>Analysts await <b>Leucadia National Corporation</b> (NYSE:LUK) to report earnings on February, 26. They expect $0.47 earnings per share, up 27.03% or $0.10 from last year's $0.37 per share. LUK's profit will be $167.45 million for 13.28 P/E if the $0.47 EPS becomes a reality. After $0.27 actual earnings per ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up